GCG and type 2 diabetes mellitus: They prevent the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), stimulate insulin synthesis, suppress glucagon secretion, inhibit appetite, reduce body weight, slow gastric emptying, and can restore functions of pancreatic beta cells providing a new approach that is effective for T2DM patients.